<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36072173</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>03</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>8</Issue><PubDate><Year>2022</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Neurological Complications of COVID-19: A Review of the Literature.</ArticleTitle><Pagination><StartPage>e27633</StartPage><MedlinePgn>e27633</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e27633</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.27633</ELocationID><Abstract><AbstractText>Coronavirus disease 2019 (COVID-19) has caused the most unprecedented health crisis since the 1918 H1N1 pandemic. Whilst COVID-19 is traditionally considered to be a respiratory disease, it is important to understand that this virus has the potential to disseminate throughout the body causing multi-organ failure. Both peripheral and central neurological systems have been shown to be greatly affected. This review aims to look at the available literature published on COVID-19 and summarize the main neurological complications seen so far.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022, Dale et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dale</LastName><ForeName>Lucy</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Foundation Year Doctor, Ninewells Hospital and Medical School, Dundee, GBR.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">brain and spine</Keyword><Keyword MajorTopicYN="N">coronavirus disease 2019 (covid-19)</Keyword><Keyword MajorTopicYN="N">intensive care unit stay</Keyword><Keyword MajorTopicYN="N">long covid</Keyword><Keyword MajorTopicYN="N">neuro-immunology</Keyword><Keyword MajorTopicYN="N">neuroinflammatory</Keyword><Keyword MajorTopicYN="N">neurological disease</Keyword><Keyword MajorTopicYN="N">public health care</Keyword><Keyword MajorTopicYN="N">spike protein and covid-19</Keyword><Keyword MajorTopicYN="N">stroke and covid-19</Keyword></KeywordList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>8</Day><Hour>2</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36072173</ArticleId><ArticleId IdType="pmc">PMC9438291</ArticleId><ArticleId IdType="doi">10.7759/cureus.27633</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organisation. WHO coronavirus (COVID-19) dashboard. https://covid19.who.int/ 2021</Citation></Reference><Reference><Citation>The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. World Health Organization. Nat Microbiol. 2020;5:536&#x2013;544.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7095448</ArticleId><ArticleId IdType="pubmed">32123347</ArticleId></ArticleIdList></Reference><Reference><Citation>Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Huang Y, Yang C, Xu XF, Xu W, Liu SW. Acta Pharmacol Sin. 2020;41:1141&#x2013;1149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7396720</ArticleId><ArticleId IdType="pubmed">32747721</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 and multiorgan response. Zaim S, Chong JH, Sankaranarayanan V, Harky A. Curr Probl Cardiol. 2020;45:100618.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7187881</ArticleId><ArticleId IdType="pubmed">32439197</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludwig PE, Varacallo M. Treasure Island, FL: StatPearls Publishing; 2019. Neuroanatomy, central nervous system (CNS)</Citation><ArticleIdList><ArticleId IdType="pubmed">28723039</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19-associated acute hemorrhagic necrotizing encephalopathy: imaging features. Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B. Radiology. 2020;296:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7233386</ArticleId><ArticleId IdType="pubmed">32228363</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. Mao L, Jin H, Wang M, et al. JAMA Neurol. 2020;77:683&#x2013;690.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Effects of COVID-19 on the nervous system. Iadecola C, Anrather J, Kamel H. Cell. 2020;183:16&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7437501</ArticleId><ArticleId IdType="pubmed">32882182</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurological manifestations associated with COVID-19: a review and a call for action. Leonardi M, Padovani A, McArthur JC. J Neurol. 2020;267:1573&#x2013;1576.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7238392</ArticleId><ArticleId IdType="pubmed">32436101</ArticleId></ArticleIdList></Reference><Reference><Citation>Mechanisms of coronavirus cell entry mediated by the viral spike protein. Belouzard S, Millet JK, Licitra BN, Whittaker GR. Viruses. 2012;4:1011&#x2013;1033.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3397359</ArticleId><ArticleId IdType="pubmed">22816037</ArticleId></ArticleIdList></Reference><Reference><Citation>Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Moher D, Liberati A, Tetzlaff J, Altman DG. PLoS Med. 2009;6:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3090117</ArticleId><ArticleId IdType="pubmed">21603045</ArticleId></ArticleIdList></Reference><Reference><Citation>Anosmia and loss of smell in the era of covid-19. Walker A, Pottinger G, Scott A, Hopkins C. BMJ. 2020;370:0.</Citation><ArticleIdList><ArticleId IdType="pubmed">32694187</ArticleId></ArticleIdList></Reference><Reference><Citation>Can the coronavirus infection penetrates the brain resulting in sudden anosmia followed by severe neurological disorders? Anwar MM, Badawi AM, Eltablawy NA. eNeurologicalSci. 2020;21:100290.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7657010</ArticleId><ArticleId IdType="pubmed">33200104</ArticleId></ArticleIdList></Reference><Reference><Citation>GOV.UK. Statement from the UK Chief Medical Officers on an update to coronavirus symptoms [Internet]. GOV.UK. https://www.gov.uk/government/news/statement-from-the-uk-chief-medical-officers-on-an-update-to-coronavirus-symptoms-18-may-2020#:~:text=restrictions%20during%20coronavirus-,Statement%20from%20the%20UK%20Chief%20Medical%20Officers%20on%20an%20update,19)%20symptoms%20has%20been%20announced.&amp;text=From%20today%2C%20all%20individuals%20should,cough%20or%20fever%20or%20anosmia. 2020</Citation></Reference><Reference><Citation>Hawkes CH, Doty RL. The Neurology of Olfaction . Cambridge, UK: Cambridge University Press; 2009.</Citation></Reference><Reference><Citation>Anosmia in COVID-19: underlying mechanisms and assessment of an olfactory route to brain infection. Butowt R, von Bartheld CS. Neuroscientist. 2021;27:582&#x2013;603.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7488171</ArticleId><ArticleId IdType="pubmed">32914699</ArticleId></ArticleIdList></Reference><Reference><Citation>Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Meinhardt J, Radke J, Dittmayer C, et al. Nat Neurosci. 2021;24:168&#x2013;175.</Citation><ArticleIdList><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurological aspects of taste disorders. Heckmann JG, Heckmann SM, Lang CJ, Hummel T. Arch Neurol. 2003;60:667&#x2013;671.</Citation><ArticleIdList><ArticleId IdType="pubmed">12756129</ArticleId></ArticleIdList></Reference><Reference><Citation>Smell and taste dysfunction in patients with COVID-19: a systematic review and meta-analysis. Agyeman AA, Chin KL, Landersdorfer CB, Liew D, Ofori-Asenso R. Mayo Clin Proc. 2020;95:1621&#x2013;1631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7275152</ArticleId><ArticleId IdType="pubmed">32753137</ArticleId></ArticleIdList></Reference><Reference><Citation>Age-dependent effects in the transmission and control of COVID-19 epidemics. Davies NG, Klepac P, Liu Y, Prem K, Jit M, Eggo RM. Nat Med. 2020;26:1205&#x2013;1211.</Citation><ArticleIdList><ArticleId IdType="pubmed">32546824</ArticleId></ArticleIdList></Reference><Reference><Citation>Why does COVID-19 disproportionately affect older people? Mueller AL, McNamara MS, Sinclair DA. Aging (Albany NY) 2020;12:9959&#x2013;9981.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7288963</ArticleId><ArticleId IdType="pubmed">32470948</ArticleId></ArticleIdList></Reference><Reference><Citation>Onset and duration of symptoms of loss of smell/taste in patients with COVID-19: a systematic review. Santos RE, da Silva MG, do Monte Silva MC, et al. Am J Otolaryngol. 2021;42:102889.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833280</ArticleId><ArticleId IdType="pubmed">33445036</ArticleId></ArticleIdList></Reference><Reference><Citation>Managing long covid: don't overlook olfactory dysfunction. Hopkins C, Burges Watson DL, Kelly C, Leary V, Smith BC. BMJ. 2020;370:0.</Citation><ArticleIdList><ArticleId IdType="pubmed">32978178</ArticleId></ArticleIdList></Reference><Reference><Citation>Evolution of altered sense of smell or taste in patients with mildly symptomatic COVID-19. Boscolo-Rizzo P, Borsetto D, Fabbris C, et al. JAMA Otolaryngol Head Neck Surg. 2020;146:729&#x2013;732.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7333173</ArticleId><ArticleId IdType="pubmed">32614442</ArticleId></ArticleIdList></Reference><Reference><Citation>Management of post-acute covid-19 in primary care. Greenhalgh T, Knight M, A'Court C, Buxton M, Husain L. BMJ. 2020;370:0.</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Characteristics and outcomes of COVID-19 associated stroke: a UK multicentre case-control study. Perry RJ, Smith CJ, Roffe C, et al. J Neurol Neurosurg Psychiatry. 2021;92:242&#x2013;248.</Citation><ArticleIdList><ArticleId IdType="pubmed">33154179</ArticleId></ArticleIdList></Reference><Reference><Citation>Risk of ischemic stroke in patients with coronavirus disease 2019 (COVID-19) vs patients with influenza. Merkler AE, Parikh NS, Mir S, et al. JAMA Neurol. 2020;77:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7333175</ArticleId><ArticleId IdType="pubmed">32614385</ArticleId></ArticleIdList></Reference><Reference><Citation>Acute cerebrovascular events with COVID-19 infection. Dhamoon MS, Thaler A, Gururangan K, et al. Stroke. 2021;52:48&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">33280551</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 related stroke in young individuals. Fifi JT, Mocco J. Lancet Neurol. 2020;19:713&#x2013;715.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7434432</ArticleId><ArticleId IdType="pubmed">32822622</ArticleId></ArticleIdList></Reference><Reference><Citation>Types of stroke: ischaemic, haemorrhagic and TIAs [Internet] Stroke Association. https://www.stroke.org.uk/what-is-stroke/types-of-stroke Stroke Association. 2021</Citation></Reference><Reference><Citation>Stroke risk factors, genetics, and prevention. Boehme AK, Esenwa C, Elkind MS. Circ Res. 2017;120:472&#x2013;495.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5321635</ArticleId><ArticleId IdType="pubmed">28154098</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemorrhagic stroke and anticoagulation in COVID-19. Dogra S, Jain R, Cao M, et al. J Stroke Cerebrovasc Dis. 2020;29:104984.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7245254</ArticleId><ArticleId IdType="pubmed">32689588</ArticleId></ArticleIdList></Reference><Reference><Citation>Risk factors for intracerebral hemorrhage in patients with COVID-19. Melmed KR, Cao M, Dogra S, et al. J Thromb Thrombol. 2021;51:953&#x2013;960.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7511245</ArticleId><ArticleId IdType="pubmed">32968850</ArticleId></ArticleIdList></Reference><Reference><Citation>Massive bilateral stroke in a COVID-19 patient. Mohamed IZ, Balson L, Madathil S. BMJ Case Rep. 2020;13:236254.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7437690</ArticleId><ArticleId IdType="pubmed">32816935</ArticleId></ArticleIdList></Reference><Reference><Citation>The looming storm: blood and cytokines in COVID-19. Kaur S, Bansal R, Kollimuttathuillam S, Gowda AM, Singh B, Mehta D, Maroules M. Blood Rev. 2021;46:100743.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7431319</ArticleId><ArticleId IdType="pubmed">32829962</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 and stroke: a review. Qi X, Keith KA, Huang JH. Brain Hemorrhages. 2020;2:76&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7670261</ArticleId><ArticleId IdType="pubmed">33225251</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroke and TIA: health topics A to Z. NICE CKS. https://cks.nice.org.uk/topics/stroke-tia/ NICE CKS. 2021`</Citation></Reference><Reference><Citation>Management of acute ischemic stroke. Phipps MS, Cronin CA. BMJ. 2020;368:0.</Citation><ArticleIdList><ArticleId IdType="pubmed">32054610</ArticleId></ArticleIdList></Reference><Reference><Citation>Ischemic stroke in COVID-19-positive patients: an overview of SARS-CoV-2 and thrombotic mechanisms for the neurointerventionalist. Zakeri A, Jadhav AP, Sullenger BA, Nimjee SM. J Neurointerv Surg. 2021;13:202&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pubmed">33298508</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroke in patients with COVID-19: clinical and neuroimaging characteristics. Vogrig A, Gigli GL, Bn&#xe0; C, Morassi M. Neurosci Lett. 2021;743:135564.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7749733</ArticleId><ArticleId IdType="pubmed">33352277</ArticleId></ArticleIdList></Reference><Reference><Citation>A case series of devastating intracranial hemorrhage during venovenous extracorporeal membrane oxygenation for COVID-19. Usman AA, Han J, Acker A, et al. J Cardiothorac Vasc Anesth. 2020;34:3006&#x2013;3012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385062</ArticleId><ArticleId IdType="pubmed">32828653</ArticleId></ArticleIdList></Reference><Reference><Citation>Intracranial hemorrhage in a young COVID-19 patient. Khattar NK, Sharma M, McCallum AP, et al. Interdiscip Neurosurg. 2020;22:100878.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7419270</ArticleId><ArticleId IdType="pubmed">32837915</ArticleId></ArticleIdList></Reference><Reference><Citation>Endovascular therapy for patients with acute ischemic stroke during the COVID-19 pandemic: a proposed algorithm. Smith MS, Bonomo J, Knight WA 4th, et al. Stroke. 2020;51:1902&#x2013;1909.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7199768</ArticleId><ArticleId IdType="pubmed">32352910</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerebral venous sinus thrombosis associated with COVID-19. Thompson A, Morgan C, Smith P, et al.  https://pubmed.ncbi.nlm.nih.gov/35067810/ Pract Neurol. 2020:0&#x2013;2678.</Citation><ArticleIdList><ArticleId IdType="pubmed">33033161</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerebral venous thrombosis in patients with COVID-19 infection: a case series and systematic review. Tu TM, Goh C, Tan YK, et al. J Stroke Cerebrovasc Dis. 2020;29:105379.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7538072</ArticleId><ArticleId IdType="pubmed">33254369</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerebral venous sinus thrombosis in COVID-19 infection: a case series and review of the literature. Dakay K, Cooper J, Bloomfield J, et al. J Stroke Cerebrovasc Dis. 2021;30:105434.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833244</ArticleId><ArticleId IdType="pubmed">33190109</ArticleId></ArticleIdList></Reference><Reference><Citation>Characteristics and outcomes in patients with COVID-19 and acute ischemic stroke: the global COVID-19 stroke registry. Ntaios G, Michel P, Georgiopoulos G, et al. Stroke. 2020;51:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7359900</ArticleId><ArticleId IdType="pubmed">32787707</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurological manifestations of COVID-19 (SARS-CoV-2): a review. Ahmed MU, Hanif M, Ali MJ, et al. Front Neurol. 2020;11:518.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7257377</ArticleId><ArticleId IdType="pubmed">32574248</ArticleId></ArticleIdList></Reference><Reference><Citation>Meningitis as an initial presentation of COVID-19: a case report. Naz S, Hanif M, Haider MA, Ali MJ, Ahmed MU, Saleem S. Front Public Health. 2020;8:474.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7536294</ArticleId><ArticleId IdType="pubmed">33072684</ArticleId></ArticleIdList></Reference><Reference><Citation>Does COVID-19 contribute to development of neurological disease? Mahalakshmi AM, Ray B, Tuladhar S, et al. Immun Inflamm Dis. 2021;9:48&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7860611</ArticleId><ArticleId IdType="pubmed">33332737</ArticleId></ArticleIdList></Reference><Reference><Citation>Bacterial and fungal infections in COVID-19 patients: a matter of concern. Zhou P, Liu Z, Chen Y, Xiao Y, Huang X, Fan XG. Infect Control Hosp Epidemiol. 2020;41:1124&#x2013;1125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7184139</ArticleId><ArticleId IdType="pubmed">32317036</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 and the brain: acute encephalitis as a clinical manifestation. Haider A, Siddiqa A, Ali N, Dhallu M. Cureus. 2020;12:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7609129</ArticleId><ArticleId IdType="pubmed">33154851</ArticleId></ArticleIdList></Reference><Reference><Citation>SARS-CoV-2 detected in cerebrospinal fluid by PCR in a case of COVID-19 encephalitis. Huang YH, Jiang D, Huang JT. Brain Behav Immun. 2020;87:149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7202824</ArticleId><ArticleId IdType="pubmed">32387508</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 meningitis without pulmonary involvement with positive cerebrospinal fluid PCR. Khodamoradi Z, Hosseini SA, Gholampoor Saadi MH, Mehrabi Z, Sasani MR, Yaghoubi S. Eur J Neurol. 2020;27:2668&#x2013;2669.</Citation><ArticleIdList><ArticleId IdType="pubmed">32926584</ArticleId></ArticleIdList></Reference><Reference><Citation>Meningococcal meningitis and COVID-19 co-infection. Gallacher SD, Seaton A. BMJ Case Rep. 2020;13:237366.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7449365</ArticleId><ArticleId IdType="pubmed">32843469</ArticleId></ArticleIdList></Reference><Reference><Citation>Meningoencephalitis associated with COVID-19: a systematic review. Mondal R, Ganguly U, Deb S, Shome G, Pramanik S, Bandyopadhyay D, Lahiri D. J Neurovirol. 2021;27:12&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7765701</ArticleId><ArticleId IdType="pubmed">33367960</ArticleId></ArticleIdList></Reference><Reference><Citation>Multiple sclerosis: pathogenesis, symptoms, diagnoses and cell-based therapy. Ghasemi N, Razavi S, Nikzad E. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241505/ Cell J. 2017;19:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5241505</ArticleId><ArticleId IdType="pubmed">28367411</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies. Garjani A, Middleton RM, Hunter R, et al. Mult Scler Relat Disord. 2021;52:102939.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9585399</ArticleId><ArticleId IdType="pubmed">34010764</ArticleId></ArticleIdList></Reference><Reference><Citation>NHS. Encephalitis: complications. https://www.nhs.uk/conditions/encephalitis/complications/ 2021</Citation></Reference><Reference><Citation>Diagnosis and treatment of neuropsychiatric disorders. Taber KH, Hurley RA, Yudofsky SC. Annu Rev Med. 2010;61:121&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">19824816</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychiatric complications of covid-19. Butler M, Pollak TA, Rooney AG, Michael BD, Nicholson TR. BMJ. 2020;371:0.</Citation><ArticleIdList><ArticleId IdType="pubmed">33051183</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study. Pun BT, Badenes R, Heras La Calle G, et al. Lancet Respir Med. 2021;9:239&#x2013;250.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832119</ArticleId><ArticleId IdType="pubmed">33428871</ArticleId></ArticleIdList></Reference><Reference><Citation>Functional and cognitive outcomes after COVID-19 delirium. Mcloughlin BC, Miles A, Webb TE, et al. Eur Geriatr Med. 2020;11:857&#x2013;862.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7358317</ArticleId><ArticleId IdType="pubmed">32666303</ArticleId></ArticleIdList></Reference><Reference><Citation>A case of catatonia in a man with COVID-19. Caan MP, Lim CT, Howard M. Psychosomatics. 2020;61:556&#x2013;560.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7251411</ArticleId><ArticleId IdType="pubmed">32605766</ArticleId></ArticleIdList></Reference><Reference><Citation>Life-threatening catatonia associated with coronavirus disease 2019. Deocleciano de Araujo C, Schlittler LX, Sguario RM, Tsukumo DM, Dalgalarrondo P, Banzato CE. J Acad Consult Liaison Psychiatry. 2021;62:256&#x2013;257.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7581393</ArticleId><ArticleId IdType="pubmed">33223217</ArticleId></ArticleIdList></Reference><Reference><Citation>The neurological symptoms of COVID-19: a systematic overview of systematic reviews, comparison with other neurological conditions and implications for healthcare services. Wildwing T, Holt N. Ther Adv Chronic Dis. 2021;12:2040622320976979.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7970685</ArticleId><ArticleId IdType="pubmed">33796241</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID and neuropsychiatric manifestations (review) Efstathiou V, Stefanou MI, Demetriou M, et al. Exp Ther Med. 2022;23:363.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9019760</ArticleId><ArticleId IdType="pubmed">35493431</ArticleId></ArticleIdList></Reference><Reference><Citation>The prevalence of long COVID symptoms and COVID-19 complications. GOV UK. https://www.ons.gov.uk/news/statementsandletters/theprevalenceoflongcovidsymptomsandcovid19complications 2020</Citation></Reference><Reference><Citation>NICE guideline on long COVID. Venkatesan P. Lancet Respir Med. 2021;9:129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832375</ArticleId><ArticleId IdType="pubmed">33453162</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuromuscular involvement in COVID-19 critically ill patients. Caba&#xf1;es-Mart&#xed;nez L, Villad&#xf3;niga M, Gonz&#xe1;lez-Rodr&#xed;guez L, et al. Clin Neurophysiol. 2020;131:2809&#x2013;2816.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7558229</ArticleId><ArticleId IdType="pubmed">33137571</ArticleId></ArticleIdList></Reference><Reference><Citation>Critical illness polyneuropathy and myopathy in COVID-19 patients: a prospective observational intensive care unit cross-sectional cohort study. Frithiof R, Rostami E, Kumlien E. https://search.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/en/ppcovidwho-310699 Virhammar J, Fallmar D, Hulstrom M et al. Critical Illness Polyneuropathy and Myopathy in COVID-19 Patients: A Prospective Observational Intensive Care Unit Cross-Sectional Cohort Study. 2020</Citation></Reference><Reference><Citation>Chronic pain after COVID-19: implications for rehabilitation. Kemp HI, Corner E, Colvin LA. Br J Anaesth. 2020;125:436&#x2013;440.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7261464</ArticleId><ArticleId IdType="pubmed">32560913</ArticleId></ArticleIdList></Reference><Reference><Citation>Critical illness polyneuropathy and critical illness myopathy. Khoiny AS, Behrouz R. https://practicalneurology.com/articles/2011-june/critical-illness-polyneuropathy-and-critical-illness-myopathy Pract Neurol. 2011:52&#x2013;56.</Citation></Reference><Reference><Citation>COVID-19: medium-to-longer term health considerations&#xD;
. https://www.physio-pedia.com/COVID-19:_Medium-to-Longer_Term_Health_Considerations 2021;19</Citation></Reference><Reference><Citation>Seneviratne SO, Patel BC. Treasure Island, FL: StatPearls Publishing; 2022. Facial nerve anatomy and clinical applications.</Citation><ArticleIdList><ArticleId IdType="pubmed">32119456</ArticleId></ArticleIdList></Reference><Reference><Citation>Can COVID-19 cause peripheral facial nerve palsy? Egilmez OK, G&#xfc;ndo&#x11f;an ME, Y&#x131;lmaz MS, G&#xfc;ven M. SN Compr Clin Med. 2021;3:1707&#x2013;1713.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8140315</ArticleId><ArticleId IdType="pubmed">34056546</ArticleId></ArticleIdList></Reference><Reference><Citation>Trigeminal neuralgia as the sole neurological manifestation of COVID-19: a case report. Molina-Gil J, Gonz&#xe1;lez-Fern&#xe1;ndez L, Garc&#xed;a-Cabo C. Headache. 2021;61:560&#x2013;562.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8251254</ArticleId><ArticleId IdType="pubmed">33749854</ArticleId></ArticleIdList></Reference><Reference><Citation>Guillain-Barr&#xe9; syndrome associated with COVID-19 disease. Korem S, Gandhi H, Dayag DB. BMJ Case Rep. 2020;13:237215.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7507330</ArticleId><ArticleId IdType="pubmed">32958554</ArticleId></ArticleIdList></Reference><Reference><Citation>Guillain-Barr&#xe9; syndrome following COVID-19: a newly emerging post-infectious complication. Webb S, Wallace VC, Martin-Lopez D, Yogarajah M. BMJ Case Rep. 2020;13:236182.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10577730</ArticleId><ArticleId IdType="pubmed">32540883</ArticleId></ArticleIdList></Reference><Reference><Citation>Campylobacter species and Guillain-Barr&#xe9; syndrome. Nachamkin I, Allos BM, Ho T. Clin Microbiol Rev. 1998;11:555&#x2013;567.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC88896</ArticleId><ArticleId IdType="pubmed">9665983</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller-Fisher syndrome after COVID-19: neurochemical markers as an early sign of nervous system involvement. Senel M, Abu-Rumeileh S, Michel D, Garibashvili T, Althaus K, Kassubek J, Otto M. Eur J Neurol. 2020;27:2378&#x2013;2380.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7436567</ArticleId><ArticleId IdType="pubmed">32781484</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller Fisher syndrome and COVID-19: is there a link? Ray A. BMJ Case Rep. 2020;13:236419.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7418682</ArticleId><ArticleId IdType="pubmed">32784241</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Varatharaj A, Thomas N, Ellul MA, et al. Lancet Psychiatry. 2020;7:875&#x2013;882.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7316461</ArticleId><ArticleId IdType="pubmed">32593341</ArticleId></ArticleIdList></Reference><Reference><Citation>A prospective study of the presentation and management of dancing eye syndrome/opsoclonus-myoclonus syndrome in the United Kingdom. Pang KK, de Sousa C, Lang B, Pike MG. Eur J Paediatr Neurol. 2010;14:156&#x2013;161.</Citation><ArticleIdList><ArticleId IdType="pubmed">19423368</ArticleId></ArticleIdList></Reference><Reference><Citation>Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature. Emamikhah M, Babadi M, Mehrabani M, et al. J Neurovirol. 2021;27:26&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7831695</ArticleId><ArticleId IdType="pubmed">33492608</ArticleId></ArticleIdList></Reference><Reference><Citation>Isolated cranial nerve 6 palsy in 6 patients with COVID-19 infection. Greer CE, Bhatt JM, Oliveira CA, Dinkin MJ. J Neuroophthalmol. 2020;40:520&#x2013;522.</Citation><ArticleIdList><ArticleId IdType="pubmed">32941331</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>